Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor | Department of Applied Biology and Chemical Technology | en_US |
| dc.contributor.advisor | Wong, Kwok-yin (ABCT) | en_US |
| dc.creator | Yin, Weile | - |
| dc.identifier.uri | https://theses.lib.polyu.edu.hk/handle/200/13934 | - |
| dc.language | English | en_US |
| dc.publisher | Hong Kong Polytechnic University | en_US |
| dc.rights | All rights reserved | en_US |
| dc.title | Synthesis and structure-activity relationship studies of thiazole derivatives as inhibitors of SARS-CoV-2 main protease | en_US |
| dcterms.abstract | Among the various potential drug targets in SARS-CoV-2, the main protease has emerged as a viable target for antiviral drug development. In this project, 42 thiazole and oxazole derivatives were designed and synthesized through a structure-based rational drug design approach. Biochemical screening and IC50 assessments indicated that 5-chloropyridin-3-yl 2-(methyl(phenyl)amino)thiazole-4-carboxylate (compound MC12) is a potent SARS-CoV-2 Mpro inhibitor, with efficacy comparable to Nirmatrelvir. Compound MC12 also displayed the inhibitory activity against SARS-CoV Mpro. The structure-activity relationship of these compounds was further explored. The mechanism of inhibition was elucidated by mass spectrometry and X-ray crystal structure as covalent bond formation between the inhibitor and target. The compounds showed minimal cytotoxicity in MTT assays on mammalian cell lines and demonstrated antiviral activity against SARS-CoV-2 in Vero E6 cells. Structural modifications of MC12, such as the derivative 5-chloropyridin-3-yl 2-(((1H-benzo[d][1,2,3]triazol-1-yI)methyl)(benzyl)-amino)thiazole-4-carboxylate (compound MC04BP01), were also explored. MC04BP01 exhibits inhibitory activity against SARS-CoV-2 Mpro similar to that used for MC12 and Nirmatrelvir. 2-Chloro-N-((S)-4-methyl-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopyrro-lidin-3-yl)propan-2-yl)amino)pentan-2-yl)thiazole-4-carboxamide (compound AD05) and 2-chloro-N-((S)-3-methyl-1-(((S)-4-methyl-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxo-pyrrolidin-3-yl)propan-2-yl)amino)pentan-2-yl)amino)-1-oxobutan-2-yl)thiazole-4-carboxamide (compound AD06), belonging to peptidomimetic derived from MC compounds, demonstrate inhibitory effects against the main protease. AD06 demonstrated an IC50 value against SARS-CoV-2 Mpro that was similar to that of Nirmatrelvir. Furthermore, the analysis of X-ray crystal structures of SARS-CoV-2 Mpro in complex with AD05 and AD06 confirmed the covalent binding mechanism of the AD series of compounds. The antiviral assay results indicated that AD05 displayed the strongest potency (EC50 = 3.264 μM) against the SARS-CoV-2 virus. These findings highlight the potential of thiazole-based compounds as promising leads in the development of SARS-CoV-2 Mpro inhibitors. | en_US |
| dcterms.extent | 1 volume (various pagings) : color illustrations | en_US |
| dcterms.isPartOf | PolyU Electronic Theses | en_US |
| dcterms.issued | 2025 | en_US |
| dcterms.educationalLevel | Ph.D. | en_US |
| dcterms.educationalLevel | All Doctorate | en_US |
| dcterms.accessRights | open access | en_US |
Copyright Undertaking
As a bona fide Library user, I declare that:
- I will abide by the rules and legal ordinances governing copyright regarding the use of the Database.
- I will use the Database for the purpose of my research or private study only and not for circulation or further reproduction or any other purpose.
- I agree to indemnify and hold the University harmless from and against any loss, damage, cost, liability or expenses arising from copyright infringement or unauthorized usage.
By downloading any item(s) listed above, you acknowledge that you have read and understood the copyright undertaking as stated above, and agree to be bound by all of its terms.
Please use this identifier to cite or link to this item:
https://theses.lib.polyu.edu.hk/handle/200/13934